Zobrazeno 1 - 10
of 730
pro vyhledávání: '"Gi cancer"'
Publikováno v:
Preventive Medicine Reports, Vol 43, Iss , Pp 102773- (2024)
Background: Upper gastrointestinal bleeding (UGIB) is a prevalent etiology for hospital admissions on a global scale. However, the significance of UGIB as a warning sign of gastrointestinal (GI) cancer is frequently disregarded due to its uncommon an
Externí odkaz:
https://doaj.org/article/ca6e9e8baf08487882309e583ac578e1
Autor:
Ahmed S. Almasoud, Mohammed Maray, Hend Khalid Alkahtani, Faiz Abdullah Alotaibi, Mrim M. Alnfiai, Ahmed Sayed
Publikováno v:
IEEE Access, Vol 12, Pp 23122-23131 (2024)
Gastrointestinal (GI) cancer comprises esophageal, gastric, colon and rectal tumors. The diagnosis of GI cancer often relies on medical imaging modalities namely magnetic resonance imaging (MRI), histopathological slides, endoscopy, and computed tomo
Externí odkaz:
https://doaj.org/article/e6852e82637441188ff9f649257b1139
Publikováno v:
Universa Medicina, Vol 43, Iss 2 (2024)
Background Gastrointestinal (GI) cancer is affecting millions of people globally, leading to high incidence and mortality rates and a heavy economic burden. Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are a family of cytosol
Externí odkaz:
https://doaj.org/article/fd0d4be3157f47ab85048a09abd35e3a
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-27 (2023)
Abstract The renin-angiotensin-aldosterone system (RAAS), is an old system with new fundamental roles in cancer biology which influences cell growth, migration, death, and metastasis. RAAS signaling enhances cell proliferation in malignancy directly
Externí odkaz:
https://doaj.org/article/61940601da504d318766b8d29b167d92
Publikováno v:
Chinese Medicine, Vol 18, Iss 1, Pp 1-18 (2023)
Abstract Gastrointestinal (GI) cancer is the most common cancer in the world and one of the main causes of cancer-related death. Clinically, surgical excision and chemotherapy are the main treatment methods for GI cancer, which is unfortunately accom
Externí odkaz:
https://doaj.org/article/fd26cb84f7344b02b28d76739029f0e8
Autor:
Hyejee Ohm, Omar Abdel-Rahman
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 786-802 (2023)
Gastrointestinal (GI) cancers are a group of malignancies that globally account for a significant portion of cancer incidence and cancer-related death. Survival outcomes for esophageal, gastric, pancreatic, and hepatobiliary cancers remain poor, but
Externí odkaz:
https://doaj.org/article/0d5ae6f7d01d4c0b93b2a1e2d56cde3a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ayako Doi, Takuro Mizukami, Hiroyuki Takeda, Kumiko Umemoto, Hiroyuki Arai, Yoshiki Horie, Naoki Izawa, Takashi Ogura, Yu Sunakawa
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundGeriatric 8 (G8) and instrumental activities of daily living (IADL) are recommended to predict overall survival (OS) or risk of serious adverse events (SAEs) in older cancer patients. However, the clinical utility is relatively unknown in o
Externí odkaz:
https://doaj.org/article/cc2a63866df247dfb637b17542a6a80b
Autor:
Dóra Lili Sindler, Péter Mátrai, Lajos Szakó, Dávid Berki, Gergő Berke, Armand Csontos, Csenge Papp, Péter Hegyi, András Papp
Publikováno v:
Frontiers in Surgery, Vol 10 (2023)
BackgroundThere were more than 1 million new cases of stomach cancer concerning oesophageal cancer, there were more than 600,000 new cases of oesophageal cancer in 2020. After a successful resection in these cases, the role of early oral feeding (EOF
Externí odkaz:
https://doaj.org/article/3e9553fa72f740668b410a7740e3d5e6
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Gastrointestinal (GI) cancer includes a variety of cancers with high incidence that seriously threaten the lives of people worldwide. Although treatment strategies continue to improve, patient benefits are still very limited, and the ongoing search f
Externí odkaz:
https://doaj.org/article/8094a6a0910e46e4b341a92b25d96c23